This test relies on Polymerase Chain Reaction (PCR) technology for the qualitative detection of Ureaplasma urealyticum bacteria DNA in clinical samples. This method is the most sensitive and specific for diagnosis, as it detects the presence of the bacteria even in low-count infections that may not show up in traditional bacterial cultures.